MOH — authorised 28 June 2012
- Marketing authorisation holder: APGDI
- Status: likely_approved
MOH authorised Myrbetriq on 28 June 2012
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 28 June 2012.
APGDI holds the UAE marketing authorisation.